TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells-Reference-Cited by-同舟云学术

TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells

Published:2015-11 Issue: Volume:69 Page:191-200
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Dreyer Anne-Kathrin,Hoffmann Dirk,Lachmann Nico^ORCID,Ackermann Mania,Steinemann Doris,Timm Barbara,Siler Ulrich,Reichenbach Janine,Grez Manuel,Moritz Thomas,Schambach Axel,Cathomen Toni^ORCID

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference55 articles.

1. Absence of both cytochrome b-245 subunits from neutrophils in X-linked chronic granulomatous disease;Segal;Nature,1987

2. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study;Güngör;Lancet,2014

3. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1;Ott;Nat. Med.,2006

4. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease;Stein;Nat. Med.,2010

5. Gene therapy of chronic granulomatous disease: the engraftment dilemma;Grez;Mol. Ther.,2011

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil generation from hematopoietic progenitor cells and induced pluripotent stem cells (iPSCs): potential applications;Cytotherapy;2024-08

2. CRISPR-Cas12a for Highly Efficient and Marker-Free Targeted Integration in Human Pluripotent Stem Cells;International Journal of Molecular Sciences;2024-01-12

3. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1;EMBO Molecular Medicine;2024-01-05

4. Cas12a Ultra enables efficient genome editing in human multipotent and pluripotent stem cells;2023-10-24

5. Progress and Prospects of Gene Editing in Pluripotent Stem Cells;Biomedicines;2023-08-01